Safety of REL-1017 for Major Depressive Disorder
Clinical trial NCT04855760 · COMPLETED
Trial details
- NCT number
- NCT04855760
- Sponsor
- Relmada Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2023-07-27
- Enrollment
- 627
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.